Researchers at Yale University School of Medicine have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus. The study, published today in the Journal of Experimental Medicine (JEM), also suggests that, rather than protecting the lungs, key antiviral signaling proteins may actually cause much of the tissue damage associated with COVID-19.
- Football-loving states slow to enact youth concussion laws
- Lab results don’t explain ‘obesity paradox,’ but bias may
- New device offers faster way to detect antibiotic-resistant bacteria
- Flashy lizards are more attractive to mates and to predators
- Octapharma USA presents bleeding disorders research at virtual ASH annual meeting